Armitage: “I am doing what I can” to keep Kappos at USPTO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Armitage: “I am doing what I can” to keep Kappos at USPTO

armitage-45.jpg

Following an announcement that he will retire as Eli Lilly’s senior vice president and general counsel at the end of this year, Robert Armitage would not indicate whether he is interested in taking over as USPTO director, instead saying he is urging Kappos to stay on

armitage.jpg

Armitage has been a leading figure in patent law for over 30 years, and was actively involved in the creation and enactment of the AIA. He will be replaced by Michael Harrington, who has been promoted from vice president and deputy general counsel, global pharmaceutical operations at Eli Lilly, effective January 1 2013.

Although Armitage said he has not decided on next steps following his retirement, he is on the IP community’s list of potential Democratic party candidates to replace David Kappos as USPTO director. While Kappos may choose to stay on if President Barack Obama is re-elected, Managing IP sources have indicated he may want to leave.

When asked if he would consider the USPTO position, Armitage described Kappos as “a uniquely talented and able director”. He added: “I am doing what I can to urge him to continue in the role, to see many of the transformational changes in the USPTO to a successful conclusion.”



more from across site and SHARED ros bottom lb

More from across our site

Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
Gift this article